A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium - Concepedia

Concepedia

Publication | Closed Access

A Clinical and Molecular Phase II Trial of Oral ENMD-2076 in Ovarian Clear Cell Carcinoma (OCCC): A Study of the Princess Margaret Phase II Consortium

64

Citations

19

References

2018

Year

Stéphanie Lheureux, Anna V. Tinker, Blaise Clarke, Prafull Ghatage, Stephen Welch, Johanne I. Weberpals, Neesha C. Dhani, Marcus O. Butler, Katia Tonkin, Qian Tan,

Clinical Cancer Research

Abstract

Single-agent ENMD-2076 did not meet the preset bar for efficacy. Loss of ARID1A correlated with better PFS on ENMD-2076 and warrants further investigation as a potential predictive biomarker.

References

	Year	Citations

Page 1